What is the treatment for urticaria multiforme?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urticaria Multiforme

H1 antihistamines are the first-line treatment for urticaria multiforme, with nonsedating options like cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine being the preferred initial therapy. 1

First-line Treatment Approach

Antihistamines

  • Nonsedating H1 antihistamines:

    • Start with standard doses of cetirizine, desloratadine, fexofenadine, levocetirizine, or loratadine once daily
    • If response is inadequate, increase the dose above the manufacturer's licensed recommendation when potential benefits outweigh risks 1
    • Offer patients at least two different nonsedating H1 antihistamines to try, as individual responses vary 1
  • For nighttime symptoms:

    • Consider sedating antihistamines if symptoms disrupt sleep
    • Low-dose doxepin can be effective, especially if associated depression is present 2

General Measures

  • Identify and minimize aggravating factors:
    • Avoid overheating, stress, and alcohol
    • Discontinue medications that may worsen urticaria (aspirin, NSAIDs, codeine)
    • Apply cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) for symptomatic relief 1

Second-line Treatment Options

When H1 Antihistamines Are Insufficient

  • Add H2 receptor antagonists:

    • Can be combined with H1 antihistamines for enhanced effect 1, 2
    • Help prevent histamine-mediated acid secretion and blunt vasoactive effects 1
    • Note: H1 and H2 blockers with anticholinergic effects may cause cognitive decline, especially in elderly patients 1
  • Consider leukotriene receptor antagonists:

    • Montelukast or zafirlukast may be beneficial, especially for dermatologic symptoms 1
    • Work best in conjunction with H1 antihistamines 1

For Severe or Refractory Cases

  • Short courses of oral corticosteroids:

    • Effective for crisis management but should be tapered quickly to limit adverse effects 1
    • Reserve for severe cases unresponsive to antihistamines 2
  • Oral cromolyn:

    • Particularly helpful for gastrointestinal symptoms 1
    • Start at lowest dose and gradually increase to 200 mg 4 times daily (before meals and at bedtime)
    • Requires at least 1 month trial to determine efficacy 1

Special Considerations

Pediatric Patients

  • Treatment approach is similar to adults, but dosing should be adjusted for age and weight 3
  • Acute episodic form is most common in children, often triggered by viruses, allergies, or physical stimuli 3

Monitoring and Follow-up

  • Evaluate response to treatment within 2-4 weeks
  • If no improvement, consider increasing antihistamine dose or adding second-line agents
  • Reassure patients that prognosis for eventual recovery is excellent, though some cases may be persistent 1

Common Pitfalls to Avoid

  • Overuse of systemic corticosteroids: Limit to short courses for severe flares
  • Inadequate antihistamine dosing: Many patients require higher than standard doses
  • Failure to identify triggers: Carefully assess for physical stimuli, medications, or foods that may exacerbate symptoms
  • Ignoring comorbidities: Consider screening for thyroid autoimmunity in chronic cases 1
  • Excessive laboratory testing: The diagnosis is primarily clinical, and investigations should be guided by history rather than performed routinely 1

Remember that urticaria has a capricious course and may resolve spontaneously. About 50% of patients are free of lesions within 1 year, though 20% may continue to have episodes for more than 20 years 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urticaria and urticaria related skin condition/disease in children.

European annals of allergy and clinical immunology, 2008

Research

Urticaria: current therapy.

The Journal of allergy and clinical immunology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.